These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22836869)

  • 1. Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; D'Angelo V; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
    Endocrine; 2013 Feb; 43(1):51-8. PubMed ID: 22836869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
    Giordano R; Bo M; Pellegrino M; Vezzari M; Baldi M; Picu A; Balbo M; Bonelli L; Migliaretti G; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineralocorticoid-, and GH-Secretagogue-receptor modulation.
    Giordano R; Pellegrino M; Picu A; Bonelli L; Balbo M; Berardelli R; Lanfranco F; Ghigo E; Arvat E
    ScientificWorldJournal; 2006 Jan; 6():1-11. PubMed ID: 16432622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of repeated maternal separation and ethanol intake on HPA axis responsiveness in adult rats.
    Odeon MM; Yamauchi L; Grosman M; Acosta GB
    Brain Res; 2017 Feb; 1657():193-201. PubMed ID: 27956119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
    Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
    Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A; Gomez R; Tenakoon L; Keller J; Cohen G; Williams GH; Kraemer FB; Schatzberg AF
    Psychoneuroendocrinology; 2013 Jan; 38(1):115-21. PubMed ID: 22727477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation.
    Ladd CO; Huot RL; Thrivikraman KV; Nemeroff CB; Plotsky PM
    Biol Psychiatry; 2004 Feb; 55(4):367-75. PubMed ID: 14960289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.
    Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
    Pituitary; 2013 Sep; 16(3):378-85. PubMed ID: 23011321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of imipramine and CORT118335 (Glucocorticoid receptor modulator/mineralocorticoid receptor antagonist) on brain-endocrine stress responses and depression-like behavior in female rats.
    Nguyen ET; Caldwell JL; Streicher J; Ghisays V; Balmer NJ; Estrada CM; Solomon MB
    Behav Brain Res; 2018 Jan; 336():99-110. PubMed ID: 28866130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
    Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of chronic stress on brain corticosteroid receptors and HPA axis activity.
    Gądek-Michalska A; Spyrka J; Rachwalska P; Tadeusz J; Bugajski J
    Pharmacol Rep; 2013; 65(5):1163-75. PubMed ID: 24399712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis.
    Rao RT; Scherholz ML; Androulakis IP
    Chronobiol Int; 2018 Nov; 35(12):1619-1636. PubMed ID: 30059634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats.
    Boero G; Pisu MG; Biggio F; Muredda L; Carta G; Banni S; Paci E; Follesa P; Concas A; Porcu P; Serra M
    Neuropharmacology; 2018 May; 133():242-253. PubMed ID: 29407214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The postnatal development of the hypothalamic-pituitary-adrenal axis in the mouse.
    Schmidt MV; Enthoven L; van der Mark M; Levine S; de Kloet ER; Oitzl MS
    Int J Dev Neurosci; 2003 May; 21(3):125-32. PubMed ID: 12711350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
    Otte C; Jahn H; Yassouridis A; Arlt J; Stober N; Maass P; Wiedemann K; Kellner M
    Life Sci; 2003 Aug; 73(14):1835-45. PubMed ID: 12888122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model.
    Brureau A; Zussy C; Delair B; Ogier C; Ixart G; Maurice T; Givalois L
    Neurobiol Aging; 2013 May; 34(5):1426-39. PubMed ID: 23273603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.